CIC
VRTX icon

Chase Investment Counsel’s Vertex Pharmaceuticals VRTX Stock Holding History

Chase Investment Counsel’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,596
Closed -$3.2M – 151
2025
Q1 		$3.2M Sell
6,596
-372
-5% -$173K 1.17% 36
2024
Q4 		$2.81M Sell
6,968
-95
-1% -$44K 0.9% 37
2024
Q3 		$3.28M Sell
7,063
-1,185
-14% -$569K 1.09% 40
2024
Q2 		$3.87M Buy
8,248
+145
+2% +$62.9K 1.37% 24
2024
Q1 		$3.39M Buy
8,103
+1,359
+20% +$575K 1.26% 29
2023
Q4 		$2.74M Sell
6,744
-436
-6% -$161K 1.21% 28
2023
Q3 		$2.5M Buy
7,180
+55
+0.8% +$19.2K 1.25% 32
2023
Q2 		$2.51M Buy
7,125
+144
+2% +$48.5K 1.26% 32
2023
Q1 		$2.2M Buy
6,981
+80
+1% +$24K 1.22% 32
2022
Q4 		$1.99M Sell
6,901
-4,535
-40% -$1.38M 1.22% 37
2022
Q3 		$3.31M Buy
11,436
+3,034
+36% +$873K 2.09% 16
2022
Q2 		$2.37M Buy
+8,402
New +$2.25M 1.28% 33
2020
Q4 		– Sell
-11,375
Closed -$3.1M – 109
2020
Q3 		$3.1M Sell
11,375
-1,886
-14% -$520K 1.54% 22
2020
Q2 		$3.85M Sell
13,261
-3,022
-19% -$819K 1.95% 12
2020
Q1 		$3.87M Buy
+16,283
New +$3.74M 2.61% 12

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chase Investment Counsel's VRTX Position: Q2 2025 in Review

Chase Investment Counsel sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 6,596 shares — an estimated $3.2M sold.

Chase Investment Counsel first reported a position in VRTX in Q1 2020 and held it in 15 quarters. The position peaked at $3.87M in Q1 2020. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Chase Investment Counsel reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Chase Investment Counsel sold 6,596 Vertex Pharmaceuticals shares in Q2 2025, an estimated $3.2M.
  • Chase Investment Counsel first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 15 quarters.
  • Chase Investment Counsel's Vertex Pharmaceuticals position peaked at $3.87M in Q1 2020.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Chase Investment Counsel's 13F filing for Q2 2025, filed 5 Aug 2025.